Medpace Holdings, Inc. (MEDP): Free Cash Flow
$681.87M
Year ended 2025-12-31
$706.69M
Trailing 12 months to 2026-06-30
+24.8%
3-year compound annual growth
+24.6%
5-year compound annual growth
+24.0%
10-year compound annual growth
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $681.87M | +19.2% | 2026-02-10, From 2025-01-01 |
| 2024-12-31 | $572.27M | +44.2% | 2026-02-10, From 2024-01-01 |
| 2023-12-31 | $396.73M | +13.0% | 2026-02-10, From 2023-01-01 |
| 2022-12-31 | $351.17M | +49.4% | 2025-02-11, From 2022-01-01 |
| 2021-12-31 | $235.06M | +3.4% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $227.34M | +23.6% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $183.96M | +30.9% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $140.56M | +64.1% | 2021-02-16, From 2018-01-01 |
| 2017-12-31 | $85.66M | +9.5% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $78.19M | -1.5% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $79.41M | n/a | 2018-02-27, From 2015-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $681.87M | +19.2% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $518.49M | +3.4% |
| Icon PLC (ICLR) | 2025-12-31 | $861.99M | -22.9% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $2.05B | -3.0% |
| NRC Health (NRC) | 2025-12-31 | $15.74M | -17.9% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$36.18M | n/m |
| OmniAb, Inc. (OABI) | 2025-12-31 | -$37.02M | n/m |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | -$3.93M | n/a |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | -$9.39M | n/m |
Compare MEDP, CRL, ICLR, IQV side by side · Screen every company in Services-Commercial Physical & Biological Research ↗